164 related articles for article (PubMed ID: 6611299)
1. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
Hagner G
Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
[TBL] [Abstract][Full Text] [Related]
2. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of responses measured by natural cytotoxicity and chemiluminescence.
Ernst M; Lange A; Flad HD; Havel A; Ennen J; Ulmer AJ
Eur J Immunol; 1984 Jul; 14(7):634-9. PubMed ID: 6430710
[TBL] [Abstract][Full Text] [Related]
5. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity.
Zarcone D; Tilden AB; Friedman HM; Grossi CE
Cancer Res; 1987 May; 47(10):2674-82. PubMed ID: 2436754
[TBL] [Abstract][Full Text] [Related]
6. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
Roozemond RC; Bonavida B
J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
[TBL] [Abstract][Full Text] [Related]
7. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
9. Induction of erythroid differentiation in K562 cells and natural killer cell-mediated lysis: distinct effects at the level of recognition and lysis in relation to target cell proliferation.
Hagner G
Immunobiology; 1984 Oct; 167(4):389-97. PubMed ID: 6595216
[TBL] [Abstract][Full Text] [Related]
10. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
Brahmi Z; Bray RA; Abrams SI
J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
[TBL] [Abstract][Full Text] [Related]
11. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
Bridges KR; Smith BR
J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
[TBL] [Abstract][Full Text] [Related]
12. Identification of a human natural killer cell target cell antigen with monoclonal antibodies.
Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL
J Immunol; 1989 Jul; 143(2):727-35. PubMed ID: 2738407
[TBL] [Abstract][Full Text] [Related]
13. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
14. Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.
Yanovich S; Hall RE; Weinert C
Cancer Res; 1986 Sep; 46(9):4511-5. PubMed ID: 2425955
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
16. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2.
Blanchard DK; Stewart WE; Klein TW; Friedman H; Djeu JY
J Immunol; 1987 Jul; 139(2):551-6. PubMed ID: 3496384
[TBL] [Abstract][Full Text] [Related]
17. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.
Freundlich B; Trinchieri G; Perussia B; Zurier RB
J Immunol; 1984 Mar; 132(3):1255-60. PubMed ID: 6693767
[TBL] [Abstract][Full Text] [Related]
18. Properties of human natural interferon-producing cells stimulated by tumor cell lines.
Rönnblom L; Ramstedt U; Alm GV
Eur J Immunol; 1983 Jun; 13(6):471-6. PubMed ID: 6574913
[TBL] [Abstract][Full Text] [Related]
19. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
20. Tumor-activated NK cells trigger monocyte oxidative metabolism.
Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
